Prot #CSLCT-AML-11-73: A Phase 1 Study of CSL362 (Anti-IL3Ra / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission with Incomplete Platelet Recovery at High Risk for Early Relapse

Project: Research project

Project Details

StatusFinished
Effective start/end date5/8/145/8/17

Funding

  • Parexel (Prot #CSLCT-AML-11-73)
  • CSL Limited (Prot #CSLCT-AML-11-73)